Key Financial Data Of Group

DAIKEN MEDICAL CO.,LTD - Filing #7303633

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of group
Business results of group
Net sales
4,914,159,000 JPY
9,750,166,000 JPY
4,824,637,000 JPY
Ordinary profit (loss)
836,343,000 JPY
1,450,000,000 JPY
750,213,000 JPY
Net assets
7,286,358,000 JPY
7,022,474,000 JPY
6,824,316,000 JPY
Total assets
11,388,472,000 JPY
11,006,318,000 JPY
11,248,693,000 JPY
Basic earnings (loss) per share
21.19
34.41
18.72
Diluted earnings per share
Equity-to-asset ratio
0.637 xbrli:pure
0.635 xbrli:pure
0.604 xbrli:pure
Net cash provided by (used in) operating activities
473,476,000 JPY
1,555,500,000 JPY
602,718,000 JPY
Net cash provided by (used in) investing activities
-76,035,000 JPY
-168,767,000 JPY
-110,942,000 JPY
Net cash provided by (used in) financing activities
20,189,000 JPY
-1,163,804,000 JPY
-350,481,000 JPY
Cash and cash equivalents
3,156,773,000 JPY
2,739,141,000 JPY
2,657,507,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.